Triggered Drug Release From Liposomes: Exploiting the Outer and Inner Tumor Environment

Abstract

Since more than 40 years liposomes have being extensively studied for their potential as carriers of anticancer drugs. The basic principle behind their use for cancer treatment consists on the idea that they can take advantage of the leaky vasculature and poor lymphatic drainage present at the tumor tissue, passively accumulating in this region. Aiming to further improve their efficacy, different strategies have been employed such as PEGlation, which enables longer circulation times, or the attachment of ligands to liposomal surface for active targeting of cancer cells. A great challenge for drug delivery to cancer treatment now, is the possibility to trigger release from nanosystems at the tumor site, providing efficacious levels of drug in the tumor. Different strategies have been proposed to exploit the outer and inner tumor environment for triggering drug release from liposomes and are the focus of this review.

Curcumin and its derivatives in cancer therapy: Potentiating antitumor activity of cisplatin and reducing side effects

“…Liposomes are spherical vesicles with an aqueous core surrounded by a phospholipid bilayer, that are able to deliver both hydrophobic and hydrophilic drugs (Franco, Gomes, Roque, & Oliveira, 2021). Recently, attention has been directed toward using liposomes for the delivery of phytochemicals, and increasing their therapeutic effects (Caddeo et al, 2021;Feng et al, 2020).…”

PEGylated Mesoporous Silica Nanoparticles (MCM-41): A Promising Carrier for the Targeted Delivery of Fenbendazole into Prostrate Cancer Cells

“…The identical charge of MCM NPs and FBZ at pH 1.2 caused electrostatic repulsion between the drug molecules and the NPs, resulting in a high rate of drug release [ 42 ]. On the other hand, the lower drug release rate from PEG-MCM-FBZ NPs compared to MCM-FBZ NPs could be attributed to the presence of PEG in the structure of the PEGylated NPs.…”

Advanced and Innovative Nano-Systems for Anticancer Targeted Drug Delivery

“…Liposome, structured by natural non-toxic phospholipids and cholesterol, is a spherical vesicle containing an aqueous inner compartment and a phospholipid bilayer, which is able to load both hydrophilic and hydrophobic cargos [43,44]. Structurally, the similar composition with the biological membrane allows cells to take up liposomes more easily and cause lower toxicity [45].…”